Literature DB >> 17586094

The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population--mainly a function of overweight?

Gunilla Hollman1, Margareta Kristenson.   

Abstract

BACKGROUND: The prevalence of obesity, one risk factor for developing the metabolic syndrome (MS), has increased during the last decades. It has therefore been assumed that the prevalence of MS would also increase. AIMS: The aim was to analyse the prevalence of MS and its risk factors in a middle-aged Swedish population.
METHODS: Data were obtained between 2003 and 2004 from a random population based sample of 502 men and 505 women, 45-69 years old. Measures of plasma glucose, serum lipids, blood pressure, weight, height, waist circumference and self-reported data concerning presence of disease, medication and lifestyle were obtained.
RESULTS: The prevalence of MS was 14.8% among men and 15.3% among women, with an increase by age among women only, 10% to 25% (p=0.029). Among individuals with MS the most frequent risk factor was large waist circumference, present in 85% of men and 99% of women, followed by high blood pressure, high triglycerides, high glucose and HDL cholesterol (38% and 47% respectively).
CONCLUSION: The prevalence of MS was 15%, increasing with age only among women. Overweight was a dominant characteristic, and only half of the individuals with MS had glucose/HDL cholesterol levels beyond defined cut points of the syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17586094     DOI: 10.1016/j.ejcnurse.2007.05.003

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  18 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

2.  Changes in mediators of inflammation and pro-thrombosis after 12 months of dietary modification in adults with metabolic syndrome.

Authors:  S K Rahamon; U A Fabian; M A Charles-Davies; J A Olaniyi; A A Fasanmade; K S Akinlade; O E Oyewole; M O Owolabi; J R Adebusuyi; O O Hassan; B M Ajobo; M O Ebesunun; K Adigun; O O Popoola; W Omiyale; O G Arinola; E O Agbedana
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

3.  Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats.

Authors:  Pengli Bao; Geli Liu; Ying Wei
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Emotional support predicts more sickness absence and poorer self assessed work ability: a two-year prospective cohort study.

Authors:  Nadine Karlsson; Elisabeth Skargren; Margareta Kristenson
Journal:  BMC Public Health       Date:  2010-10-26       Impact factor: 3.295

Review 5.  Metabolic syndrome: definitions and controversies.

Authors:  Eva Kassi; Panagiota Pervanidou; Gregory Kaltsas; George Chrousos
Journal:  BMC Med       Date:  2011-05-05       Impact factor: 8.775

6.  Population-based metabolic syndrome risk score and its determinants: The Isfahan Healthy Heart Program.

Authors:  Mohsen Hosseini; Nizal Sarrafzadegan; Roya Kelishadi; Mehri Monajemi; Sedigheh Asgary; Hossein Molavi Vardanjani
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

7.  Prevalence of the metabolic syndrome in a rural population in Ghana.

Authors:  Mawuli Gyakobo; Albert Gb Amoah; De-Anne Martey-Marbell; Rachel C Snow
Journal:  BMC Endocr Disord       Date:  2012-10-30       Impact factor: 2.763

8.  Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia.

Authors:  Alireza Esteghamati; Alipasha Meysamie; Omid Khalilzadeh; Armin Rashidi; Mehrdad Haghazali; Fereshteh Asgari; Mandana Kamgar; Mohammad Mehdi Gouya; Mehrshad Abbasi
Journal:  BMC Public Health       Date:  2009-05-29       Impact factor: 3.295

9.  Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population.

Authors:  Peter Garvin; Lennart Nilsson; John Carstensen; Lena Jonasson; Margareta Kristenson
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

10.  Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study.

Authors:  Sanjib Saha; Katarina Steen Carlsson; Ulf-G Gerdtham; Margareta K Eriksson; Lars Hagberg; Mats Eliasson; Pia Johansson
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.